Brief: Cogent Biosciences Q2 EPS USD -0.59
06/08/2024 13:00
Aug 06 (Reuters) - Cogent Biosciences Q2 operating expenses USD 64.387 million. * Q2 net income USD -58.95 million * Q2 income from operations USD -64.387 million
Recent news on Cogent Biosciences
See all newsBrief: Cogent Biosciences - Enters Commercial Supply Agreement With Hovione On Sept 1, 2026 - SEC Filing
Brief: Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
Cogent Biosciences Q2 net loss widens on higher expenses
Brief: Cogent Biosciences Q2 Net Income USD -96.405 Million
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's